WHO WATCH: The Utility of Pathogen Genomics — Spotlight TB

Description

‘This webinar is part of a series hosted on EPI-WIN by the International Pathogen Surveillance Network (IPSN).  IPSN is a global network of pathogen genomic actors, brought together by the WHO Hub for Pandemic and Epidemic Intelligence, part of the WHO Health Emergencies Programme (WHE) , to accelerate progress in pathogen genomics, and improve public health decision-making.  To inform country capacity building activities the webinar series aims to provide a forum for expert and evidence-based discussions on the role of genomics with a focus on providing high level context to countries and funders about its utility in various settings.  This webinar series has been prepared in collaboration with the Taskforce for Global Health and Science for Africa Foundation.

‘This webinar will spotlight the utility of genomics for surveillance and clinical management of Tuberculosis, as the leading cause of death from any single infectious pathogen worldwide. Participants will have an expanded understanding of the history, experience, and resources for drug-resistant TB sequencing as foundational for building and sustaining disease and cross-purpose capacity in many settings. Speakers will present current and future perspectives on the applicability of genomics to drug-resistant TB sequencing across a range of settings for emerging and circulating pathogen surveillance and clinical case management, exploring important topics that include recent innovations in sequencing approaches, implementation models, and intelligence sharing.’

Speakers

• Tim Dallman — Senior Technical Officer, Emerging Pathogen Intelligence Platforms Unit, WHO Health Emergency Preparedness & Response Programme
• Patricia Hall-Eidson — Team Lead, TB Prevention, Diagnosis,Treatment,Care & Innovation, WHO Global Tuberculosis Programme
• Anita Suresh — Deputy Director, Genomics & Sequencing, FIND

Shaheed Vally Omar — Medical Scientist, Centre for Tuberculosis, National Institute for Communicable Diseases (NICD), South Africa

• Greg Armstrong — Taskforce for Global Health
• Catxon Murira — Programme Lead for Clinical Trials and Research Community, Science for Africa Foundation
• Josefina Campos — Unit Head, Emerging Pathogen Intelligence Platforms, WHO Health Emergency Preparedness & Response Programme